Securities code: Lifecome Biochemistry Co.Ltd(002868) securities abbreviation: Lifecome Biochemistry Co.Ltd(002868) Announcement No.: 2022038 Lifecome Biochemistry Co.Ltd(002868)
Announcement on the resolution of the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. There was no increase, rejection or change of proposals during the shareholders’ meeting.
2. The general meeting of shareholders adopts the combination of on-site voting and online voting. 1、 Meetings held
1. Notice of meeting
Lifecome Biochemistry Co.Ltd(002868) (hereinafter referred to as “the company” or ” Lifecome Biochemistry Co.Ltd(002868) “) was published in Securities Daily and cninfo on April 12, 2022（ http://www.cn.info.com.cn. ）The announcement on the notice of convening the 2021 annual general meeting of shareholders (Announcement No.: 2022025) was published.
2. Meeting time
The on-site meeting will be held at 15:00 on Wednesday, May 18, 2022.
Online voting time: May 18, 2022. The time of online voting through the trading system of Shenzhen stock exchange is: 9:15-9:25 a.m., 9:30-11:30 a.m. and 13:00-15:00 p.m. on May 18, 2022; The specific time of voting through the Internet system of Shenzhen stock exchange is any time from 9:15 to 15:00 on May 18, 2022.
3. Venue of on-site meeting: conference room 1 on the second floor of the company’s comprehensive office building
4. Convener: Board of directors
5. Meeting mode: the combination of on-site voting and online voting
6. Host of the on-site meeting: Mr. Lai Tanping, chairman of the company
7. The convening and convening of the meeting shall comply with the company law, the rules for the general meeting of shareholders of listed companies, the rules for the listing of shares, the articles of association and other relevant provisions. 2、 Attendance at the meeting
General attendance of shareholders:
There were 14 shareholders who voted on site and online, representing 111745045 shares, accounting for 719007% of the total shares of the listed company.
Among them, 11 shareholders voted on the spot, representing 64452995 shares, accounting for 414713% of the total shares of the listed company.
Three shareholders voted online, representing 47292050 shares, accounting for 304294% of the total shares of the listed company.
Overall attendance of minority shareholders:
One minority shareholder voted on the spot and online, representing 650 shares, accounting for 0.0004% of the total shares of the listed company.
Among them: 0 minority shareholders passed the on-site voting.
One minority shareholder voted online, representing 650 shares, accounting for 0.0004% of the total shares of the listed company. 3、 Deliberation and voting of proposal 1.00 general voting of the proposal on the work report of the board of directors of the company in 2021:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 2.00 proposal on the work report of the board of supervisors in 2021
Total voting:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Voting on the 202300 annual budget proposal of the company:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 4.00 general voting of the company’s 2021 profit distribution plan:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for
100% of the shares held by minority shareholders; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 5.00 general voting of the company’s proposal on the remuneration scheme of directors and supervisors in 2022:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Total voting of proposal 6.00 proposal on the proposed reappointment of audit institutions in 2022:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 7.00 general voting on the proposal on the full text and summary of the company’s 2021 annual report:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Total voting of proposal 8.00 proposal on the prediction of guarantee amount for subsidiaries:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 9.00 general voting of the proposal on Amending the articles of association:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting.
Proposal 10.00 general voting of the proposal on Amending the rules of procedure of the company’s general meeting of shareholders:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 11.00 general voting of the proposal on Amending the rules of procedure of the board of directors:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. Proposal 12.00 general voting of the proposal on Amending the rules of procedure of the board of supervisors:
111744395 shares were agreed, accounting for 999994% of the shares held by all shareholders attending the meeting; Against 650 shares, accounting for 0.0006% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting. Total voting of minority shareholders:
Agree to 0 shares, accounting for 0% of the shares held by minority shareholders attending the meeting; Against 650 shares, accounting for 100% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. 4、 Lawyer witness
Affected by the epidemic of pneumonia caused by novel coronavirus, the shareholders’ meeting was witnessed by the lawyer of Shanghai Chengming Zezheng law firm via video, and issued a legal opinion. It is believed that the convening and holding procedures of the company’s shareholders’ meeting comply with the provisions of relevant laws, regulations, normative documents and the articles of association, and the qualifications of the people attending the meeting are legal and valid, The voting procedures and results of this general meeting of shareholders are legal and valid. 5、 Documents for future reference
1. Resolution of Lifecome Biochemistry Co.Ltd(002868) 2021 annual general meeting of shareholders
2. Legal opinion on Lifecome Biochemistry Co.Ltd(002868) 2021 annual general meeting of shareholders issued by Shanghai Chengming Zezheng law firm
It is hereby announced.
Lifecome Biochemistry Co.Ltd(002868) board of directors
